Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 2014-03
Thoracic re-irradiation using stereotactic body radiotherapy (SBRT) techniques as first or second course of treatment.
Abstract
Background and purpose
Management for in-field failures after thoracic radiation is poorly defined. We evaluated SBRT as an initial or second course of treatment re-irradiating in a prior high dose region.
Materials and methods
Thirty-three patients were treated with re-irradiation defined by the prior 30 Gy isodose line. Kaplan-Meier estimates were performed for local (LC), regional (RC), distant control (DC), and overall survival (OS). The plans when available were summed to evaluate doses to critical structures. Patient and treatment variables were analyzed on UVA for the impact on control and survival measures.
Results
Median follow-up was 17 months. Treatment for sequential courses was as follows: (course1:course2) EBRT:SBRT (24 patients), SBRT:SBRT (7 patients), and SBRT:EBRT (3 patients). Median re-irradiation dose and fractionation was 50 Gy and 10 fractions (fx), with a median of 18 months (6-61) between treatments. Median OS was 21 months and 2 year LC 67%, yet LC for >1 fraction was 88% (p=0.006 for single vs. multiple). 10 patients suffered chronic grade 2-3 toxicity (6 chest wall pain, 3 dyspnea, 1 esophagitis) and 1 grade 5 toxicity with aorta-esophageal fistula after 54 Gy in 3 fx for a central tumor with an estimated EQD2 to the aorta of 200 Gy.
Conclusion
Tumor control can be established with re-irradiation using SBRT techniques for in-field thoracic failures at the cost of manageable toxicity.
Related Questions
Would you treat an in-field recurrence/marginal recurrence of NSCLC following previous definitive chemoradiation with salvage SBRT?
I would layer the answer to the patient. First question: Local control, yes or no. If yes, then when... to answer that discussion of systemic option and timing in multiD eval. If yes, then how... surgery, IR thermal ablation, radiation. If radiation then dose/technique... 50 Gy 5 fx, 50 Gy 10 fx, 50...
How do you evaluate and constrain the cumulative lung DVH for inoperable patients who have received multiple courses of lung SBRT and now require fractionated mediastinal RT?
This is an increasingly common problem and there are few data to guide decision making.However, some have looked at dosimetric-toxicity relationships in the reirradiation setting (either re-SABR or conventional radiation after SABR).It's suggested that composite high dose to a previously irradiated ...